Julie Elizabeth Buring, Sc.D.
Title Professor of Medicine Institution Brigham and Women's Hospital Address Brigham and Women's Hospital East, 3rd Floor 900 Commonwealth Ave Boston MA 02215
|
|
Title
Professor in the Department of Epidemiology
Institution
Harvard T.H. Chan School of Public Health

Biography
2001
Honorary Doctorate Degree
2002
Roger L. Nichols Excellence in Teaching Award
2007
Roger L. Nichols Excellence in Teaching Award
2008
John Snow Award, Epidemiology Section

Overview
The primary focus of my research has been on the epidemiology of chronic diseases, particularly cardiovascular disease and cancer, and especially among women. I am Principal Investigator or co-Principal Investigator of four large-scale randomized clinical trials or their observational follow-up: the Women's Health Study, a primary prevention trial that evaluated the balance of benefits and risks of low dose aspirin and vitamin E on cardiovascular disease and cancer among 40,000 female health professionals; the Women's Antioxidant Cardiovascular Study, a secondary prevention trial that evaluated the roles of vitamin E, vitamin C, beta-carotene and folic acid/B6/B12 among 8,000 women with a prior history of heart disease; the Physicians' Health Study II, that evaluated vitamin E, vitamin C, beta-carotene and a multivitamin among 15,000 male physicians; and the Brigham and Women's Hospital Vanguard Center of the Women's Health Initiative, that evaluated the roles of low-fat diet, postmenopausal hormones, and calcium/vitamin D supplementation among over 70,000 women nationwide.
I am actively involved in the teaching and training of students and fellows in epidemiology, both nationally and internationally. I serve as Director of EPI 200: Principles of Epidemiology, a core course at the Harvard School of Public Health, am Director of a T32 NRSA Training Grant funded by the NIA in the Epidemiology of Aging, and Co-Program Director of a similar training grant in the Epidemiology of Cardiovascular Disease, funded by the NHLBI.

Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
U01CA182913
(BURING, JULIE E. ;LEE, I-MIN)
Sep 17, 2014 - Aug 31, 2024
Women's Health Study: Infrastructure support for cohort follow-up
Role: Principal Investigator
-
UM1CA182913
(BURING, JULIE E.)
Sep 17, 2014 - Aug 31, 2019
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up
Role: Principal Investigator
-
R01AT005065
(BURING, JULIE E.)
Sep 30, 2010 - Feb 28, 2017
Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital
Role: Principal Investigator
-
RC1HL099355
(BURING, JULIE E)
Sep 30, 2009 - Jul 31, 2011
The Women's Health Study: Addition of New Data to Maximize its Research Impact
Role: Principal Investigator
-
R01AT011729
(BURING, JULIE E.;MANSON, JOANN ELISABETH)
Sep 29, 2009 - Jun 30, 2026
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up
Role: Co-Principal Investigator
-
R01CA138962
(MANSON, JOANN ELISABETH)
Sep 29, 2009 - May 31, 2021
The VITamin D and OmegA-3 TriaL (VITAL)
Role: Principal Investigator
-
U01CA138962
(MANSON, JOANN ELISABETH)
Sep 29, 2009 - Jun 30, 2015
VITamin D and omegA-3 triaL (VITAL)
Role: Principal Investigator
-
R01HL080467
(BURING, JULIE E)
Apr 20, 2005 - Mar 31, 2012
Women's Health Study: Continued Follow-Up
Role: Principal Investigator
-
R01NS034108
(BURING, JULIE E)
May 19, 1995 - Apr 30, 1998
LOW DOSE ASPIRIN IN THE PROPHYLAXIS OF MIGRAINE HEADACHE
Role: Principal Investigator
-
R01HL043851
(BURING, JULIE E)
Sep 30, 1991 - Aug 31, 2002
TRIAL OF ASPIRIN AND VITAMIN E IN WOMEN
Role: Principal Investigator
-
R01CA047988
(BURING, JULIE E.)
Feb 1, 1991 - Dec 31, 2015
Women's Health Study: Continued Follow-up
Role: Principal Investigator
-
R01HL042441
(BURING, JULIE E)
Jan 1, 1990 - Dec 31, 1993
RANDOMIZED TRIAL OF MDS: STUDY OF LOW CV MORTALITY
Role: Principal Investigator
-
R01EY008427
(BURING, JULIE E)
Dec 1, 1989 - Nov 30, 1993
TRIAL OF BETA-CAROTENE AND MACULAR DEGENERATION
Role: Principal Investigator
-
T32AG000158
(GAZIANO, J. MICHAEL)
Jun 1, 1988 - Apr 30, 2017
Training Program in Epidemiologic Research on Aging
Role: Co-Principal Investigator
-
U01HL037852
(HENNEKENS, CHARLES H)
Sep 30, 1986 - Jun 30, 1998
COORDINATIONG CENTER--TRIALS OF HYPERTENSION PREVENTION
Role: Co-Principal Investigator
-
R01EY006633
(CHRISTEN, WILLIAM G)
Aug 1, 1986 - Jun 30, 2004
RANDOMIZED TRIALS OF VITAMIN SUPPLEMENTS AND EYE DISEASE
Role: Co-Principal Investigator
-
R01HL034594
(MANSON, JOANN ELISABETH ;QI, LU)
Dec 1, 1984 - Feb 29, 2024
Risk Factors for CVD in Women
Role: Co-Principal Investigator
-
R01CA040360
(BURING, JULIE E)
Dec 1, 1984 - May 31, 2003
PHYSICIANS HEALTH STUDY--CONTINUED FOLLOW UP
Role: Principal Investigator
-
R01HL034595
(BURING, JULIE E)
Dec 1, 1984 - Nov 30, 1991
TRIAL OF ASPIRIN AND BETA-CAROTENE IN U S MD'S
Role: Principal Investigator
-
T32HL007575
(RIDKER, PAUL M.)
Jul 1, 1984 - Oct 31, 2020
Training Program in the Epidemiology of CVD
Role: Principal Investigator

Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu. SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).